Guidance
Recommendations for research
The guideline committee has made the following recommendation for research.
1 Methenamine hippurate use in other populations
What is the clinical and cost effectiveness of methenamine hippurate when compared with antibiotics in the prevention of recurrent urinary tract infections (UTIs) for men, pregnant women, children, young people, older people and people with upper UTI or complicated lower UTI? [2024]
For a short explanation of why the committee made the recommendation for research, see the evidence and committee discussion on methenamine hippurate.
Full details of the evidence and the committee's discussion are in evidence review B: effectiveness of methenamine hippurate in the prevention of recurrent UTIs.